Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Net Cash Flow (2016 - 2020)

Historic Net Cash Flow for Larimar Therapeutics (LRMR) over the last 8 years, with Q4 2020 value amounting to -$33.2 million.

  • Larimar Therapeutics' Net Cash Flow fell 63590.77% to -$33.2 million in Q4 2020 from the same period last year, while for Dec 2020 it was $68.5 million, marking a year-over-year increase of 212178.92%. This contributed to the annual value of $5.7 million for FY2024, which is 496837.61% up from last year.
  • Latest data reveals that Larimar Therapeutics reported Net Cash Flow of -$33.2 million as of Q4 2020, which was down 63590.77% from -$11.4 million recorded in Q3 2020.
  • Larimar Therapeutics' 5-year Net Cash Flow high stood at $113.1 million for Q2 2020, and its period low was -$33.2 million during Q4 2020.
  • Its 5-year average for Net Cash Flow is $3.9 million, with a median of $1.5 million in 2017.
  • The largest annual percentage gain for Larimar Therapeutics' Net Cash Flow in the last 5 years was 122139.94% (2020), contrasted with its biggest fall of 63590.77% (2020).
  • Quarter analysis of 5 years shows Larimar Therapeutics' Net Cash Flow stood at $7.5 million in 2016, then skyrocketed by 188.13% to $21.6 million in 2017, then crashed by 80.59% to $4.2 million in 2018, then plummeted by 207.54% to -$4.5 million in 2019, then plummeted by 635.91% to -$33.2 million in 2020.
  • Its Net Cash Flow stands at -$33.2 million for Q4 2020, versus -$11.4 million for Q3 2020 and $113.1 million for Q2 2020.